{"filings":[{"id":888210,"accession_number":"0001193125-26-259530","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-06-05T20:05:17+00:00","items":["5.07"],"status":"ready","headline":"Definitive Healthcare shareholders approve 15M share increase under 2021 equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment to 2021 Equity Incentive Plan approved: shares authorized increase from 30.97M to 45.97M (15M new shares).","All three Class II director nominees elected: Chris Egan, Sastry Chilukuri, Samuel Hamood.","Deloitte & Touche LLP ratified as independent auditor for fiscal year 2026; 130.7M for, 0.7M against.","Advisory say-on-pay approved with 108.8M for, 12.7M against, 19.2k abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.15,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96363,"accession_number":"0001193125-26-211946","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q1 revenue $55.9M (-6% YoY); net loss $192.4M on $197M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $55.9M, at top end of guidance, down 6% from $59.2M in Q1 2025.","Net loss of $(192.4)M includes $197.2M goodwill impairment; adjusted net income rose to $8.5M from $7.0M.","Adjusted EBITDA $15.3M (27% margin) vs $14.7M (25%) YoY; operating cash flow $11.6M, unlevered FCF $18.0M.","Q2 2026 guidance: revenue $55-56M, adj. EBITDA $13.5-14.5M. Full-year: revenue $220-226M, adj. EBITDA $55-59M.","Customer wins include a six-figure multi-year life sciences deal and Monocl expansion from a biopharma acquisition."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":55929000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96362,"accession_number":"0001193125-26-149605","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-04-09T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Definitive Healthcare terminates nominating agreement with Spectrum; designee resigned","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Spectrum had right to designate one director nominee while holding ≥5% of outstanding shares.","Jeff Haywood, Spectrum's designee, resigned from board on March 30, 2026.","On April 3, 2026, Definitive Healthcare and Spectrum permanently terminated the Nominating Agreement.","Termination removes Spectrum's board nomination right effective immediately.","No reason for termination disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96361,"accession_number":"0001193125-26-142104","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-04-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare director Jeff Haywood resigns from Board and Compensation Committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeff Haywood resigned from the Board and Compensation Committee effective March 30, 2026.","Resignation was not due to any disagreement with the Company's operations, policies, or practices.","Board size reduced from 9 to 8 members; Compensation Committee reduced from 3 to 2 members."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110209,"accession_number":"0001193125-26-076609","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q4 revenue $61.5M (-1% YoY); full year net loss includes $196.1M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $61.5M vs $62.3M prior year; adjusted EBITDA $18.0M (29% margin) vs $17.5M (28%).","Full year 2025 revenue $241.5M vs $252.2M; adjusted net income $34.9M vs $55.1M.","Net loss for full year 2025 was $199.3M, including $196.1M goodwill impairment; prior year loss $591.4M with $688.9M impairment.","Q1 2026 revenue guidance $54–56M; full year 2026 revenue guidance $220–226M, below 2025 actual of $241.5M.","Customer wins: large health system for Population Intelligence; global rare disease firm for US market expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":241521000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126766,"accession_number":"0001193125-25-269559","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q3 revenue $60M (-4% YoY); net loss $17.8M; raises FY revenue guidance low end","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $60.0M (-4% vs $62.7M in Q3 2024); net loss $17.8M (vs $187.8M including $228.2M goodwill impairment).","Adjusted EBITDA $18.9M (32% margin), down from $20.6M (33% margin) YoY; adjusted net income $9.7M.","Q4 2025 revenue guidance $59-60M; FY 2025 revenue guidance raised to $239-240M (low end up $2M).","Customer wins: large biopharma and medical device company selected Definitive Healthcare for commercial intelligence.","Cash flow from operations $15.7M; unlevered free cash flow $17.9M in Q3 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":179987000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143552,"accession_number":"0000950170-25-105037","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q2 revenue $60.8M (-5% YoY); raises FY revenue guidance bottom by $3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net loss $(9.3)M vs $(306.2)M (prior year included $363.6M goodwill impairment).","Adjusted net income $9.7M, down from $14.2M in Q2 2024; adjusted EBITDA $18.7M (31% margin).","Q3 2025 revenue guidance $59-60M; FY 2025 raised to $237-240M from $234-240M.","Adjusted net income per diluted share for Q3 guided at $0.05-0.06; FY at $0.22-0.23.","Customer wins include a revenue cycle management firm and a digital health org returning after non-renewal."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":119941000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143551,"accession_number":"0000950170-25-097966","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Jill Larsen resigns from Definitive Healthcare board; Scott Stephenson named Compensation Committee Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jill Larsen resigned from the Board and as Chair of the Human Capital Management and Compensation Committee effective July 21, 2025.","Resignation due to increased responsibilities at her current employer, not due to any disagreement with the Company.","Board size reduced from 10 to 9 members.","Scott Stephenson appointed as member and Chair of the Compensation Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143550,"accession_number":"0000950170-25-092187","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-07-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare eliminates COO role; Shamsuddin Jensen to depart Aug 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO position eliminated; Kate Shamsuddin Jensen will remain employed through August 1, 2025.","Departure treated as termination without 'cause' under company's plans and agreements.","No replacement named; role eliminated as part of organizational design planning.","Agreement reached on June 25, 2025; effective date of departure is August 1, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161746,"accession_number":"0000950170-25-083070","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Definitive Healthcare stockholders elect three Class I directors, ratify auditor, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Kevin Coop, Jason Krantz, and Lauren Young elected Class I directors with 118M, 117M, and 108M votes for, respectively.","Ratification of Deloitte & Touche as FY2025 auditor passed with 129.4M votes for, 3.0M against, 163K abstain.","Advisory vote on executive compensation approved with 108.6M for, 12.9M against, 167.6K abstain, plus 10.9M broker non-votes.","Record date for the June 5, 2025 annual meeting was April 14, 2025, with 107.96M Class A and 39.0M Class B shares outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161745,"accession_number":"0000950170-25-066957","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q1 revenue $59.2M (-7% YoY); net loss $155M on $176.5M goodwill impairment; FY guidance raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $59.2M, down 7% YoY; net loss $155.1M including $176.5M goodwill impairment.","Adjusted EBITDA $14.7M (25% margin) vs $20.0M (32% margin) a year ago.","Full-year revenue guidance raised: $234-$240M (prior $230-$240M); reaffirmed adjusted EBITDA margin 26-28%.","Cash flow from operations $26.1M; unlevered free cash flow $22.9M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.95,"consensus_revenue_estimate":null,"consensus_revenue_actual":59191000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179835,"accession_number":"0000950170-25-029049","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q4 revenue $62.3M (-6% YoY); guides FY2025 $230-240M; names Casey Heller CFO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $62.3M, -6% YoY; net loss $(84.7)M including $97.1M goodwill impairment.","Full-year 2024 revenue $252.2M (flat YoY); net loss $(591.4)M with $688.9M impairment.","Q4 adjusted net income $12.6M vs $10.6M; FY adjusted EBITDA $79.1M, 31% margin.","FY2025 revenue guidance $230-240M (down ~5-9% YoY); Q1 rev $55.5-57.0M.","Casey Heller appointed CFO effective June 2, 2025; succeeds Richard Booth (departs June 1)."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":252202000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179834,"accession_number":"0000950170-25-006199","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-01-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Definitive Healthcare enters $175M term loan and $50M revolver, maturing Jan 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $175M term loan facility and $50M revolving credit facility with Bank of America as agent; matures January 16, 2030.","Proceeds used to repay outstanding indebtedness under existing credit agreement and pay related fees and expenses.","Term loan amortizes at 5.0% of original principal quarterly starting first full fiscal quarter after closing; balance due at maturity.","Interest rates: ABR plus 1.00%-1.50% or Term SOFR plus 2.00%-2.50%, with two 0.25% step-ups based on total net leverage ratio.","Facilities guaranteed by all wholly-owned domestic restricted subsidiaries and direct parent AIDH Buyer, LLC; secured by substantially all assets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196604,"accession_number":"0000950170-24-123356","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","5.02","8.01","9.01"],"status":"ready","headline":"Definitive Healthcare Q3 revenue beats at $62.7M; CFO Booth to depart June 2025; $100M buyback authorized","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $62.7M, down 4% YoY; net loss $(187.8)M includes $228.2M goodwill impairment; adjusted EBITDA $20.6M (33% margin).","CFO Richard Booth to leave effective June 1, 2025; granted 92,379 RSUs as retention incentive; search for successor underway.","Board authorized $100M stock repurchase program expiring Dec 31, 2025; replaces prior $20M program; no repurchases yet.","Entered voting agreement with Advent International to limit excess voting shares above 40.3% proportionally.","Guidance: Q4 revenue $60-61M, adjusted EBITDA $16-17M; full-year revenue $250-251M, adjusted EBITDA $77.5-78.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":189914000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196603,"accession_number":"0000950170-24-110816","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare promotes Kate Shamsuddin Jensen to COO effective Oct 1","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ms. Shamsuddin Jensen, previously Chief Strategy Officer, named Chief Operating Officer.","New annual base salary of $360,000; eligible for annual cash bonus target of 60% of salary.","Granted 113,379 time-vesting RSUs valued at $500,000 vesting over two years.","Promotion effective October 1, 2024; she joined the company in 2015."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212910,"accession_number":"0000950170-24-090774","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q2 revenue $63.7M (+5% YoY); net loss $(306.2)M on $363.6M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $63.7M (+5% YoY); net loss $(306.2)M including $363.6M goodwill impairment (up 2,538% from $(11.6)M).","Adjusted EBITDA $20.9M (33% margin) vs $17.2M; Adjusted Net Income $14.2M vs $12.4M.","Enterprise customers grew 6% YoY to 537; cash from ops $14.0M, unlevered FCF $21.5M.","Q3 2024 guidance: revenue $61-62.5M; adj. EBITDA $17.5-19M. FY2024 revenue $247-251M; adj. EBITDA $74-77M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":127217000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212909,"accession_number":"0000950170-24-087900","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-07-30T23:59:59+00:00","items":["2.02","5.02"],"status":"ready","headline":"Definitive Healthcare Q2 prelim revenue $63.7M (+5% YoY), goodwill impairment $363.6M; CRO resigns","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Revenue $63.7M (+5% YoY); adjusted EBITDA $20.9M (33% margin) vs $17.2M (28%) YoY.","Net loss $(306.2)M ($(1.81)/share) includes $363.6M goodwill impairment; adjusted net income $0.09/share.","FY2024 guidance: revenue $247-251M, adjusted EBITDA $74-77M (30-31% margin), adjusted EPS $0.32-0.34.","CRO Carrie Lazorchak resigns effective Aug 2, 2024; sales organization reports to CEO Kevin Coop.","Adjusted operating income $19.3M vs $16.0M YoY, up 20.5%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212908,"accession_number":"0000950170-24-082121","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare grants CEO Kevin Coop 186,192 RSUs as make-whole award","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["RSU award granted July 4, 2024 to compensate for equity grant shortfall due to share price volatility.","RSUs vest 25% on July 1, 2025, then 6.25% quarterly over three years, subject to continued employment.","Grant follows CEO appointment effective June 24, 2024, previously disclosed on May 24, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231986,"accession_number":"0000950170-24-064571","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Appoints Kevin Coop as CEO effective June 24; Founder Krantz remains Executive Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin Coop appointed CEO effective June 24, 2024; founder Jason Krantz steps down as interim CEO but stays as Executive Chairman.","Coop receives base salary $500k, target bonus 100%, initial RSU grant of $7.5M value, and performance PSUs with stock price hurdles $10-$27.","At annual meeting, stockholders elected three Class III directors, ratified Deloitte as auditor, and approved say-on-pay on a non-binding basis.","2023 Inducement Plan amended to increase reserved shares to 4.4 million for the inducement grants to Coop."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231985,"accession_number":"0000950170-24-054479","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q1 revenue $63.5M (+7% YoY); Adj. EBITDA margin 32%; $20M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $63.5M, +7% YoY from $59.2M; net loss narrowed to $12.7M from $16.0M.","Adjusted Net Income $13.0M vs $9.1M; Adjusted EBITDA $20.0M (32% margin vs 26%).","Enterprise customers grew 6% YoY to 559; added 30 clients with >$100K ARR.","Board authorized $20M stock repurchase program through end of 2024.","FY2024 guidance: revenue $255-$261M (+1-4%); Q2 revenue $62-$63.5M (+2-4%)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":63480000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250265,"accession_number":"0000950170-24-022110","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare reports Q4 rev $65.9M (+9% YoY); FY23 net loss $289.6M; guides FY24 rev $263-269M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $65.9M (+9% YoY); FY23 revenue $251.4M (+13% YoY).","Q4 net loss $13.4M (20% of rev) vs net income $5.9M in Q4 2022; FY23 net loss $289.6M.","Adjusted EBITDA Q4 $19.8M (30% margin); FY23 $74.5M (30% margin).","Guidance: Q1 2024 rev $63–65M (6–10% YoY); FY2024 rev $263–269M (5–7% YoY).","Added 28 enterprise clients in Q4; total enterprise customers at 565 with >$100K ARR."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":251415000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}